ZURICH (Reuters) – Roche has launched a new PCR test to detect a fast-spreading sub-variant of the Omicron variant of Coronavirus, the Swiss drugmaker said on Thursday. The new test specifically targets…
By Natalie Grover LONDON (Reuters) – The results of a key Alzheimer’s drug trial on Wednesday have reignited decades-old hopes that targeting a particular protein helps arrest the progression of the fatal…
ZURICH – Roche has received approval from the U.S. Food and Drugs Administration for its Xofluza drug to treat influenza in children aged five years and older, the drugmaker said on Friday.…